| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |